(1 - 7 von 8
)
New AIDS drug shows promise in animal tests - UPI Archives
www.upi.com
Swedish researchers Monday presented a drug they claim is four to five times better in fighting the AIDS virus than AZT, the only drug approved by the U.S....
B-MS turns its back on HIV pact with Sweden's Medivir - PharmaTimes
www.pharmatimes.com
Sweden’s Medivir has been told that partner Bristol-Myers Squibb has terminated the development of the firms’ preclinical HIV compound MIV News -...
Bristol-Myers Squibb Axes Development of Anti-HIV Candidate
www.genengnews.com
While the company was eligible to milestones worth $97 million and double-digit royalties, Bo Oberg, CEO of Medivir HIV Franchise, is satisfied ...
BMS Drops Medivir HIV Drug - Contract Pharmawww.contractpharma.com › view_breaking-news
www.contractpharma.com
· ... that by far exceed Medivir's investments in the project" said professor Bo Oberg, chief executive officer of Medivir HIV Franchise AB.
Swedish biotech licenses HIV drug to China for development | aidsmap
www.aidsmap.com
Professor Bo Oberg, head of the HIV franchise at Medivir, told aidsmap: “This should enhance the safety of condoms and will at least save a few ...
Bo Öberg Joins Clanotech's Board of Directors - Karolinska...
news.cision.com
Stockholm, Sweden, March 25, Clanotech AB, a Karolinska Development portfolio
Bo Öberg and Nils-Gunnar Johansson have sold B-class shares - Medivir
news.cision.com
Medivir’s 70-year old founders Bo Öberg and Nils-Gunnar Johansson have today sold 100,000 and 150,
sortiert nach Relevanz / Datum